Do not prescribe proton pump inhibitors (PPIs) during steroid therapy or for long periods in patients who exhibit dyspeptic symptoms.
There is no evidence supporting the routine use of proton pump inhibitors (PPIs) in patients diagnosed with functional dyspepsia or as prophylaxis against iatrogenic injury during treatment with corticosteroids. The main risk associated with discontinuing PPIs in...
Do not prescribe abdominal ultrasound (or other imaging) follow-up for patients with asymptomatic hepatic hemangiomas smaller than 10 cm and without history of chronic liver disease.
Hepatic hemangiomas are the most common non-cystic benign liver lesions, with a prevalence of up to 20% in the general population, and sizes ranging from a few millimeters to more than 20 cm. They result from an abnormality in angiogenesis and have no malignant...
Do not repeat esophagogastroduodenoscopy (EGD) in patients diagnosed with gastroesophageal reflux disease (GERD), unless the examination is part of the follow-up of precancerous epithelial conditions (Barrett’s esophagus) or in the event of new alarm symptoms.
Endoscopy in gastroesophageal reflux disease (GERD) should be reserved for patients who do not respond to an 8-week course of empirical therapy with proton pump inhibitors, for patients with extraesophageal symptoms that do not respond to therapy, for those presenting...
Do not perform surveillance colonoscopy for colon polyps after a valid exam with intervals that vary from those indicated by the responsible gastroenterologist after histologic evaluation of the polyp.
The timing of surveillance colonoscopies is determined by the findings of the initial endoscopic examination and is guided by evidence-based guidelines that assess the relative risk of developing new adenomas or carcinomas. The most appropriate interval should be...The campaign DOING MORE DOES NOT MEAN DOING BETTER – CHOOSING WISELY ITALY is promoted by Italy’s Slow Medicine
Recent Comments